100% Quality Guarantee
PhD-Level Technical Support
Anti-OX40 (ivuxoli biosimilar) (HDBS0052)
Key Features

Ivuxolimab Biosimilar (OX40) Antibody (HDBS0052)

SKU HDBS0052
Antibody Type Biosimilar Reference Antibody
Applications IHC
Applications FC
Applications Drug Development
Applications Pharmacokinetics
Disease Area Cancer
Protein OX40
Reactivity Human
Host Species Human
Isotype IgG2
€431

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheet

Ivuxolimab Biosimilar (OX40) Antibody (HDBS0052)

The OX40 (Ivuxoli) Biosimilar (HDBS0052) offered by Assay Genie is a cutting-edge product designed for research involving OX40, a co-stimulatory molecule involved in the activation and regulation of T cells. This biosimilar antibody, designed to mimic the activity of OX40, is produced using innovative technology to ensure high specificity and functionality in various research applications.This product is ideal for studies focusing on the role of OX40 in immune responses, inflammation, and cancer immunotherapy. With its high reactivity and specificity for OX40, researchers can confidently use this biosimilar antibody in techniques such as flow cytometry, immunohistochemistry, and functional assays to investigate the function and expression of OX40 in different cell types and disease contexts.

The Anti-OX40 (Ivuxoli) Biosimilar (HDBS0052) from Assay Genie represents a valuable tool for advancing research in immunology, oncology, and autoimmune diseases, providing researchers with a reliable and effective means to explore the intricate mechanisms of OX40 signaling and its potential as a therapeutic target.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose